Cutler Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Cutler Group’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-306	Closed	-$40K	–	4623
2022 Q3	$40K	Buy	+306	New	+$42.9K	﹤0.01%	2061
2022 Q1	–	Sell	-1,200	Closed	-$178K	–	5529
2021 Q4	$194K	Buy	+1,200	New	+$194K	0.01%	1342
2017 Q3	–	Sell	-200	Closed	-$23.7K	–	6086
2017 Q2	$22K	Sell	200 -350	-64%	-$37.6K	﹤0.01%	3316
2017 Q1	$57K	Buy	+550	New	+$55.1K	﹤0.01%	2274
2016 Q4	–	Sell	-50	Closed	-$4.68K	–	6734
2016 Q3	$4K	Sell	50 -100	-67%	-$9.81K	﹤0.01%	5131
2016 Q2	$13K	Buy	150 +100	+200%	+$9.19K	﹤0.01%	3834
2016 Q1	$4K	Sell	50 -130	-72%	-$11.5K	﹤0.01%	5028
2015 Q4	$20K	Buy	+180	New	+$19.4K	﹤0.01%	3412

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Cutler Group's FBT Position: Q4 2022 in Review

Cutler Group sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2022, closing a stake of 306 shares — an estimated $40K sold.

Cutler Group first reported a position in FBT in Q4 2015 and held it in 8 quarters. The position peaked at $194K in Q4 2021. 243 funds tracked by Wall St. Rank hold FBT as of Q4 2022.

Cutler Group reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2022 after selling out during the quarter.
Cutler Group sold 306 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2022, an estimated $40K.
Cutler Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2015 and held it in 8 quarters.
Cutler Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $194K in Q4 2021.
243 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.